WOLF FORMULATIONS LIMITED - Period Ending 2017-04-30

WOLF FORMULATIONS LIMITED - Period Ending 2017-04-30


WOLF FORMULATIONS LIMITED SC474279 false 2016-05-01 2017-04-30 2017-04-30 The principal activity of the company is manufacture of personal and household care products. Digita Accounts Production Advanced 6.20.8420.0 Software true SC474279 2016-05-01 2017-04-30 SC474279 2017-04-30 SC474279 bus:Director2 1 2017-04-30 SC474279 bus:Director3 1 2017-04-30 SC474279 bus:Director5 1 2017-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2017-04-30 SC474279 core:ShareCapital 2017-04-30 SC474279 core:CurrentFinancialInstruments 2017-04-30 SC474279 core:CurrentFinancialInstruments core:WithinOneYear 2017-04-30 SC474279 core:PatentsTrademarksLicencesConcessionsSimilar 2017-04-30 SC474279 core:FurnitureFittingsToolsEquipment 2017-04-30 SC474279 core:OtherPropertyPlantEquipment 2017-04-30 SC474279 bus:SmallEntities 2016-05-01 2017-04-30 SC474279 bus:AuditExemptWithAccountantsReport 2016-05-01 2017-04-30 SC474279 bus:FullAccounts 2016-05-01 2017-04-30 SC474279 bus:RegisteredOffice 2016-05-01 2017-04-30 SC474279 bus:Director2 2016-05-01 2017-04-30 SC474279 bus:Director2 1 2016-05-01 2017-04-30 SC474279 bus:Director3 2016-05-01 2017-04-30 SC474279 bus:Director3 1 2016-05-01 2017-04-30 SC474279 bus:Director5 2016-05-01 2017-04-30 SC474279 bus:Director5 1 2016-05-01 2017-04-30 SC474279 bus:PrivateLimitedCompanyLtd 2016-05-01 2017-04-30 SC474279 bus:Agent1 2016-05-01 2017-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2016-05-01 2017-04-30 SC474279 core:ShareCapital 2016-05-01 2017-04-30 SC474279 core:PatentsTrademarksLicencesConcessionsSimilar 2016-05-01 2017-04-30 SC474279 core:RecipesFormulaeModelsDesignsPrototypes 2016-05-01 2017-04-30 SC474279 core:ComputerEquipment 2016-05-01 2017-04-30 SC474279 core:FurnitureFittings 2016-05-01 2017-04-30 SC474279 core:FurnitureFittingsToolsEquipment 2016-05-01 2017-04-30 SC474279 core:OtherPropertyPlantEquipment 2016-05-01 2017-04-30 SC474279 core:PlantMachinery 2016-05-01 2017-04-30 SC474279 core:OtherRelatedParties 2016-05-01 2017-04-30 SC474279 countries:Scotland 2016-05-01 2017-04-30 SC474279 2016-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2016-04-30 SC474279 core:ShareCapital 2016-04-30 SC474279 core:PatentsTrademarksLicencesConcessionsSimilar 2016-04-30 SC474279 core:FurnitureFittingsToolsEquipment 2016-04-30 SC474279 core:OtherPropertyPlantEquipment 2016-04-30 SC474279 2015-05-01 2016-04-30 SC474279 2016-04-30 SC474279 bus:Director2 1 2016-04-30 SC474279 bus:Director3 1 2016-04-30 SC474279 bus:Director5 1 2016-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2016-04-30 SC474279 core:ShareCapital 2016-04-30 SC474279 core:CurrentFinancialInstruments 2016-04-30 SC474279 core:CurrentFinancialInstruments core:WithinOneYear 2016-04-30 SC474279 core:PatentsTrademarksLicencesConcessionsSimilar 2016-04-30 SC474279 core:FurnitureFittingsToolsEquipment 2016-04-30 SC474279 core:OtherPropertyPlantEquipment 2016-04-30 SC474279 bus:Director2 1 2015-05-01 2016-04-30 SC474279 bus:Director3 1 2015-05-01 2016-04-30 SC474279 bus:Director5 1 2015-05-01 2016-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2015-05-01 2016-04-30 SC474279 core:ShareCapital 2015-05-01 2016-04-30 SC474279 2015-04-30 SC474279 core:RetainedEarningsAccumulatedLosses 2015-04-30 SC474279 core:ShareCapital 2015-04-30 iso4217:GBP

Registration number: SC474279

WOLF FORMULATIONS LIMITED

Annual Report and Unaudited Financial Statements

for the Year Ended 30 April 2017

Mint Accounting Ltd
56 King Street
Aberdeen
AB24 5AX

 

WOLF FORMULATIONS LIMITED

Contents

Company Information

1

Accountants' Report

2

Statement of Comprehensive Income

3

Balance Sheet

4 to 5

Statement of Changes in Equity

6

Notes to the Financial Statements

7 to 16

 

WOLF FORMULATIONS LIMITED

Company Information

Directors

Mr Max Wolf

Mr Frederick George Scott Dalgarno

Mr William Beattie

Registered office

Newton Of Countesswells
Kingswells
Aberdeen
AB15 8QB

Accountants

Mint Accounting Ltd
56 King Street
Aberdeen
AB24 5AX

 

Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
WOLF FORMULATIONS LIMITED
for the Year Ended 30 April 2017

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of WOLF FORMULATIONS LIMITED for the year ended 30 April 2017 as set out on pages 3 to 16 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Chartered Institute of Management Accountants (CIMA), we are subject to its ethical and other professional requirements which are detailed at http://www.cimaglobal.com/members/.

This report is made solely to the Board of Directors of WOLF FORMULATIONS LIMITED, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of WOLF FORMULATIONS LIMITED and state those matters that we have agreed to state to the Board of Directors of WOLF FORMULATIONS LIMITED, as a body, in this report in accordance with CIMA. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than WOLF FORMULATIONS LIMITED and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that WOLF FORMULATIONS LIMITED has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of WOLF FORMULATIONS LIMITED. You consider that WOLF FORMULATIONS LIMITED is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of WOLF FORMULATIONS LIMITED. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Mint Accounting Ltd
56 King Street
Aberdeen
AB24 5AX

26 September 2017

 

WOLF FORMULATIONS LIMITED

Statement of Comprehensive Income for the Year Ended 30 April 2017

Note

2017
£

2016
£

Loss for the year

 

(132,968)

(107,165)

Total comprehensive income for the year

 

(132,968)

(107,165)

 

WOLF FORMULATIONS LIMITED

(Registration number: SC474279)
Balance Sheet as at 30 April 2017

Note

2017
£

2016
£

Fixed assets

 

Intangible assets

3

56,000

63,000

Tangible assets

4

4,575

5,843

 

60,575

68,843

Current assets

 

Stocks

5

48,754

31,306

Debtors

6

3,972

4,056

Cash at bank and in hand

 

810

10

 

53,536

35,372

Creditors: Amounts falling due within one year

7

(225,206)

(82,342)

Net current liabilities

 

(171,670)

(46,970)

Net (liabilities)/assets

 

(111,095)

21,873

Capital and reserves

 

Called up share capital

220,000

220,000

Profit and loss account

(331,095)

(198,127)

Total equity

 

(111,095)

21,873

For the financial year ending 30 April 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

WOLF FORMULATIONS LIMITED

(Registration number: SC474279)
Balance Sheet as at 30 April 2017

Approved and authorised by the Board on 26 September 2017 and signed on its behalf by:
 

.........................................

Mr Max Wolf

Director

.........................................

Mr Frederick George Scott Dalgarno

Director

.........................................

Mr William Beattie

Director

 

WOLF FORMULATIONS LIMITED

Statement of Changes in Equity for the Year Ended 30 April 2017

Share capital
£

Profit and loss account
£

Total
£

At 1 May 2016

220,000

(198,127)

21,873

Loss for the year

-

(132,968)

(132,968)

Total comprehensive income

-

(132,968)

(132,968)

At 30 April 2017

220,000

(331,095)

(111,095)

Share capital
£

Profit and loss account
£

Total
£

At 1 May 2015

220,000

(90,962)

129,038

Loss for the year

-

(107,165)

(107,165)

Total comprehensive income

-

(107,165)

(107,165)

At 30 April 2016

220,000

(198,127)

21,873

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

1

General information

The company is a private company limited by share capital incorporated in Scotland.

The address of its registered office is:
Newton Of Countesswells
Kingswells
Aberdeen
AB15 8QB

These financial statements were authorised for issue by the Board on 26 September 2017.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

25% on cost

Fixtures and fittings

20% on cost

Plant and machinery

20% on cost

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Cleaning products formulae

10% on cost

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

3

Intangible assets

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

At 1 May 2016

70,000

70,000

At 30 April 2017

70,000

70,000

Amortisation

At 1 May 2016

7,000

7,000

Amortisation charge

7,000

7,000

At 30 April 2017

14,000

14,000

Carrying amount

At 30 April 2017

56,000

56,000

At 30 April 2016

63,000

63,000

The aggregate amount of research and development expenditure recognised as an expense during the period is £319 (2016 - £9,785).
 

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

4

Tangible assets

Furniture, fittings and equipment
 £

Other property, plant and equipment
 £

Total
£

Cost or valuation

At 1 May 2016

6,566

544

7,110

Additions

207

-

207

At 30 April 2017

6,773

544

7,317

Depreciation

At 1 May 2016

1,149

118

1,267

Charge for the year

1,366

109

1,475

At 30 April 2017

2,515

227

2,742

Carrying amount

At 30 April 2017

4,258

317

4,575

At 30 April 2016

5,417

426

5,843

5

Stocks

2017
£

2016
£

Other inventories

48,754

31,306

6

Debtors

2017
£

2016
£

Trade debtors

1,998

953

Other debtors

1,974

3,103

Total current trade and other debtors

3,972

4,056

7

Creditors

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Note

2017
£

2016
£

Due within one year

 

Bank loans and overdrafts

8

111,935

50,942

Trade creditors

 

34,166

23,075

Taxation and social security

 

2,522

3,779

Other creditors

 

76,583

4,546

 

225,206

82,342

8

Loans and borrowings

2017
£

2016
£

Current loans and borrowings

Bank overdrafts

9,563

9,842

Other borrowings

102,372

41,100

111,935

50,942

9

Related party transactions

Transactions with directors

2017

At 1 May 2016
£

Advances to directors
£

Repayments by director
£

At 30 April 2017
£

Mr Frederick George Scott Dalgarno

During the year the director provided the company with an interest free loan, which is unsecured, repayable on demand and shown under Other Creditors.

(9,696)

5,221

(17,345)

(21,821)

         
       

Mr Max Wolf

During the year the director provided the company with an interest free loan, which is unsecured, repayable on demand and shown under Other Creditors.

(23,404)

12,484

(17,953)

(28,873)

         
       

Mr William Beattie

During the year the director provided the company with an interest bearing loan, which is unsecured, repayable on demand and shown under Other Creditors.

(8,000)

-

(43,679)

(51,679)

         
       

 
 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

2016

At 1 May 2015
£

Advances to directors
£

Repayments by director
£

At 30 April 2016
£

Mr Frederick George Scott Dalgarno

During the year the director provided the company with an interest free loan, which is unsecured, repayable on demand and shown under Other Creditors.

(61,271)

64,774

(13,200)

(9,696)

         
       

Mr Max Wolf

During the year the director provided the company with an interest free loan, which is unsecured, repayable on demand and shown under Other Creditors.

(72,133)

115,192

(66,462)

(23,404)

         
       

Mr William Beattie

During the year the director provided the company with an interest bearing loan, which is unsecured, repayable on demand and shown under Other Creditors.

-

50,000

(58,000)

(8,000)

         
       

 

Summary of transactions with other related parties

Mr N. Dalgarno
 Shareholder
 During the year Mr N. Dalgarno, shareholder, provided the company with an interest free loan, which is unsecured, repayable on demand and shown under Other Creditors. At the balance sheet date the amount owed to Mr N. Dalgarno was £29,750 (2016 £0).
 

10

Transition to FRS 102

There have been no reclassifications or remeasurements on transition to FRS102.

Balance Sheet at 1 May 2015
 

Note

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Fixed assets

 

Intangible assets

 

70,000

-

-

70,000

Tangible assets

 

3,328

-

-

3,328

 

73,328

-

-

73,328

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Note

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Current assets

 

Debtors

 

2,350

-

-

2,350

Cash at bank and in hand

 

508

-

-

508

 

2,858

-

-

2,858

Creditors: Amounts falling due within one year

 

(167,147)

-

-

(167,147)

Net current liabilities

 

(164,289)

-

-

(164,289)

Net liabilities

 

(90,961)

-

-

(90,961)

Capital and reserves

 

Called up share capital

 

(1)

-

-

(1)

Profit and loss account

 

90,962

-

-

90,962

Total equity

 

90,961

-

-

90,961

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Balance Sheet at 30 April 2016
 

Note

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Fixed assets

 

Intangible assets

 

63,000

-

-

63,000

Tangible assets

 

5,843

-

-

5,843

 

68,843

-

-

68,843

Current assets

 

Stocks

 

31,306

-

-

31,306

Debtors

 

4,056

-

-

4,056

Cash at bank and in hand

 

10

-

-

10

 

35,372

-

-

35,372

Creditors: Amounts falling due within one year

 

(82,342)

-

-

(82,342)

Net current liabilities

 

(46,970)

-

-

(46,970)

Net assets

 

21,873

-

-

21,873

Capital and reserves

 

Called up share capital

 

(220,000)

-

-

(220,000)

Profit and loss account

 

198,127

-

-

198,127

Total equity

 

(21,873)

-

-

(21,873)

 

WOLF FORMULATIONS LIMITED

Notes to the Financial Statements for the Year Ended 30 April 2017

Profit and Loss Account for the year ended 30 April 2016
 

Note

As originally reported
£

Reclassification
£

Remeasurement
£

As restated
£

Turnover

 

8,800

-

-

8,800

Cost of sales

 

(9,680)

-

-

(9,680)

Gross loss

 

(880)

-

-

(880)

Administrative expenses

 

(106,218)

-

-

(106,218)

Operating loss

 

(107,098)

-

-

(107,098)

Interest payable and similar expenses

 

(67)

-

-

(67)

 

(67)

-

-

(67)

Loss before tax

 

(107,165)

-

-

(107,165)

Loss for the financial year

 

(107,165)

-

-

(107,165)